|
HUP9902721A2
(hu)
*
|
1997-11-25 |
1999-12-28 |
The Procter & Gamble Co. |
Tömény textillágyító készítmény és ehhez alkalmazható magas telítetlenségű textillágyító vegyület
|
|
KR20010073190A
(ko)
*
|
1998-09-28 |
2001-07-31 |
제임스 알. 데니히 |
백내장 형성 억제제
|
|
US6914057B1
(en)
|
1998-09-28 |
2005-07-05 |
The Research Foundation Of State University Of New York |
Inhibitor of cataract formation
|
|
WO2002072146A2
(en)
*
|
2001-03-12 |
2002-09-19 |
Novartis Ag |
Combination of nateglinide or repaglinide with at least one further antidiabetic compound
|
|
AU2002256092C1
(en)
*
|
2001-04-05 |
2009-10-15 |
Collagenex Pharmaceuticals, Inc. |
Controlled delivery of tetracycline compounds and tetracycline derivatives
|
|
FR2826278B1
(fr)
*
|
2001-06-20 |
2005-03-25 |
Lipha |
Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
|
|
EP1397124B1
(fr)
*
|
2001-06-20 |
2006-11-29 |
Merck Sante |
Utilisation d'agents antidiabetiques pour fabriquer un medicament ayant un effet cicatrisant
|
|
EP2329826A1
(en)
|
2001-07-13 |
2011-06-08 |
Paratek Pharmaceuticals, Inc. |
Tetracyclines for the treatment of multiple sclerosis
|
|
AU2002359730A1
(en)
*
|
2001-12-21 |
2003-07-30 |
Smithkline Beecham Corporation |
Compositions and methods for altering glucose production
|
|
EP2311799A1
(en)
|
2002-01-08 |
2011-04-20 |
Paratek Pharmaceuticals, Inc. |
4-dedimethylamino tetracycline compounds
|
|
JP2005526754A
(ja)
|
2002-03-08 |
2005-09-08 |
パラテック ファーマシューティカルズ インコーポレイテッド |
アミノメチル置換されたテトラサイクリン化合物
|
|
KR101083498B1
(ko)
|
2002-03-21 |
2011-11-16 |
파라테크 파마슈티컬스, 인크. |
치환된 테트라시클린 화합물
|
|
CA2492273C
(en)
|
2002-07-12 |
2013-02-05 |
Paratek Pharmaceuticals, Inc. |
3, 10, and 12a substituted tetracycline compounds
|
|
ES2534827T3
(es)
|
2003-04-07 |
2015-04-29 |
Supernus Pharmaceuticals, Inc. |
Formulaciones de tetraciclinas en dosis única diaria
|
|
CA2531728A1
(en)
|
2003-07-09 |
2005-02-03 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
JP4738333B2
(ja)
|
2003-07-09 |
2011-08-03 |
パラテック ファーマシューティカルズ インコーポレイテッド |
９−アミノメチルテトラサイクリン化合物のプロドラッグ
|
|
CA2553510C
(en)
*
|
2004-01-15 |
2012-09-25 |
Paratek Pharmaceuticals, Inc. |
Aromatic a-ring derivatives of tetracycline compounds
|
|
EP2269985A3
(en)
|
2004-10-25 |
2011-09-21 |
Paratek Pharmaceuticals, Inc. |
Substituted tetracycline compounds
|
|
AU2005299294B2
(en)
|
2004-10-25 |
2012-06-07 |
Paratek Pharmaceuticals, Inc. |
4-aminotetracyclines and methods of use thereof
|
|
JP2009502809A
(ja)
*
|
2005-07-21 |
2009-01-29 |
パラテック ファーマシューティカルズ インコーポレイテッド |
１０−置換テトラサイクリンおよびその使用方法
|
|
US20070098763A1
(en)
*
|
2005-10-11 |
2007-05-03 |
Sinnott Robert A |
Soluble Fiber Combinations for Weight Control and Improving Parameters of Cardiovascular Health
|
|
PT2120963T
(pt)
|
2006-12-21 |
2018-12-17 |
Paratek Pharm Innc |
Compostos tetraciclina substituídos para tratamento de distúrbios inflamatórios da pele
|
|
PL2109602T3
(pl)
*
|
2006-12-21 |
2014-09-30 |
Paratek Pharm Innc |
Pochodne tetracyliny do leczenia zakażeń bakteryjnych, wirusowych i pasożytniczych
|
|
JP2010525069A
(ja)
*
|
2007-04-27 |
2010-07-22 |
パラテック ファーマシューティカルズ インコーポレイテッド |
アミノアルキルテトラサイクリン化合物の合成方法および精製方法
|
|
BRPI0823405A2
(pt)
*
|
2007-07-06 |
2012-12-25 |
Paratek Pharmaceuticals, Inc. |
mÉtodos para sintetizar compostos de tetraciclina substituÍda
|
|
TW202216656A
(zh)
|
2008-05-19 |
2022-05-01 |
美商Ｐｒｔｋ Ｓｐｖ２公司 |
四環素化合物之甲苯磺酸鹽及同素異形體
|
|
PT2323972E
(pt)
|
2008-08-08 |
2013-10-09 |
Tetraphase Pharmaceuticals Inc |
Compostos de tetraciclina substituídos com c7-flúor
|
|
EP2427425B1
(en)
|
2009-05-08 |
2017-03-08 |
Tetraphase Pharmaceuticals, Inc. |
Tetracycline compounds
|
|
IN2012DN02502A
(https=)
|
2009-08-28 |
2015-08-28 |
Tetraphase Pharmaceuticals Inc |
|
|
TWI592390B
(zh)
|
2010-03-31 |
2017-07-21 |
四相製藥公司 |
聚環狀四環素化合物
|
|
BR112015004523B1
(pt)
|
2012-08-31 |
2020-08-04 |
Tetraphase Pharmaceuticals, Inc |
Compostos de tetraciclina, composições farmacêuticas e seus usos
|
|
US9171343B1
(en)
|
2012-09-11 |
2015-10-27 |
Aseko, Inc. |
Means and method for improved glycemic control for diabetic patients
|
|
US9897565B1
(en)
|
2012-09-11 |
2018-02-20 |
Aseko, Inc. |
System and method for optimizing insulin dosages for diabetic subjects
|
|
US9898585B2
(en)
|
2014-01-31 |
2018-02-20 |
Aseko, Inc. |
Method and system for insulin management
|
|
US9486580B2
(en)
|
2014-01-31 |
2016-11-08 |
Aseko, Inc. |
Insulin management
|
|
US11081226B2
(en)
|
2014-10-27 |
2021-08-03 |
Aseko, Inc. |
Method and controller for administering recommended insulin dosages to a patient
|
|
AU2015339576B2
(en)
|
2014-10-27 |
2020-02-06 |
Glytec, Llc |
Subcutaneous outpatient management
|
|
WO2017031440A1
(en)
|
2015-08-20 |
2017-02-23 |
Aseko, Inc. |
Diabetes management therapy advisor
|
|
CN110582486B
(zh)
|
2016-10-19 |
2024-01-12 |
四相制药公司 |
艾若威四环素的结晶形式
|
|
US12570604B2
(en)
|
2018-11-09 |
2026-03-10 |
Tetraphase Pharmaceuticals, Inc. |
Polymorphic forms of a tetracycline compound and uses thereof
|
|
WO2020232227A1
(en)
|
2019-05-14 |
2020-11-19 |
Tyme, Inc. |
Compositions and methods for treating cancer
|
|
US20230165940A1
(en)
*
|
2020-04-08 |
2023-06-01 |
Hoffman Technologies Llc |
Methods of treating conditions characterized by insulin deficiency in animals
|
|
US10905698B1
(en)
|
2020-05-14 |
2021-02-02 |
Tyme, Inc. |
Methods of treating SARS-COV-2 infections
|